U.S. Clinical Nutrition Market Size, Share, Forecast – 2032

U.S. Clinical Nutrition Market - By Product (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), By Consumer (Pediatric, Adult), By Application (Metabolic Disorders, Neurological Diseases), Distribution Channel, Dosage Formulation & Forecast, 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at country level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Business trends

Chapter 3&nbsp;&nbsp;&nbsp;US Clinical Nutrition Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 - 2032 (USD Million)

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing metabolic disorders and other chronic diseases

3.2.1.2&nbsp;&nbsp;&nbsp;High junk food consumption leading to malnourishment

3.2.1.3&nbsp;&nbsp;&nbsp;Rising geriatric population

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing incidence of pre-mature birth &amp; birth rate

3.2.1.5&nbsp;&nbsp;&nbsp;Increasing adoption of home healthcare

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent government regulations

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By consumer

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By distribution channel

3.3.5&nbsp;&nbsp;&nbsp; By dosage formulation

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Key market trends

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Supply chain analysis for clinical nutrition

3.8&nbsp;&nbsp;&nbsp; Dietary supplements usage scenario in U.S.

3.9&nbsp;&nbsp;&nbsp; Regulatory landscape

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;US Clinical Nutrition Market, By Product

5.1&nbsp;&nbsp;&nbsp; Key product trends

5.2&nbsp;&nbsp;&nbsp; Infant nutrition

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.2&nbsp;&nbsp;&nbsp; Milk based

5.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.3&nbsp;&nbsp;&nbsp; Soy based

5.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.4&nbsp;&nbsp;&nbsp; Organic formulas

5.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.5&nbsp;&nbsp;&nbsp; Others

5.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Enteral nutrition

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.2&nbsp;&nbsp;&nbsp; Standard composition

5.3.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.3&nbsp;&nbsp;&nbsp; Disease specific composition

5.3.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Parenteral nutrition

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.2&nbsp;&nbsp;&nbsp; Amino acids

5.4.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.3&nbsp;&nbsp;&nbsp; Fats

5.4.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.4&nbsp;&nbsp;&nbsp; Carbohydrates

5.4.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.5&nbsp;&nbsp;&nbsp; Others

5.4.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;US Clinical Nutrition Market, By Consumer

6.1&nbsp;&nbsp;&nbsp; Key consumer trends

6.2&nbsp;&nbsp;&nbsp; Pediatric

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Adult

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;US Clinical Nutrition Market, By Application

7.1&nbsp;&nbsp;&nbsp; Key application trends

7.2&nbsp;&nbsp;&nbsp; Cancer

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Metabolic disorders

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Neurological diseases

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Gastrointestinal disorders

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.6&nbsp;&nbsp;&nbsp; Others

7.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;US Clinical Nutrition Market, By Distribution Channel

8.1&nbsp;&nbsp;&nbsp; Key distribution channel trends

8.2&nbsp;&nbsp;&nbsp; Retail stores

8.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.3&nbsp;&nbsp;&nbsp; Pharmacies &amp; drug stores

8.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.4&nbsp;&nbsp;&nbsp; Online channels

8.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.5&nbsp;&nbsp;&nbsp; Others

8.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9&nbsp;&nbsp;&nbsp;US Clinical Nutrition Market, By Dosage Formulation

9.1&nbsp;&nbsp;&nbsp; Key dosage formulation trends

9.2&nbsp;&nbsp;&nbsp; Powder

9.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.3&nbsp;&nbsp;&nbsp; Liquid

9.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.4&nbsp;&nbsp;&nbsp; Solid

9.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories (Abbott Nutrition)

10.2&nbsp;&nbsp;&nbsp; B Braun Melsungen AG

10.3&nbsp;&nbsp;&nbsp; Baxter International Inc.

10.4&nbsp;&nbsp;&nbsp; Fresenius Kabi

10.5&nbsp;&nbsp;&nbsp; Mead Johnson (Reckitt Benckiser)

10.6&nbsp;&nbsp;&nbsp; Nestle Health Science

10.7&nbsp;&nbsp;&nbsp; Perrigo

10.8&nbsp;&nbsp;&nbsp; Pfizer, Inc.

10.9&nbsp;&nbsp;&nbsp; Danone

10.10&nbsp;&nbsp;&nbsp; Hero Nutritionals Inc.

10.11&nbsp;&nbsp;&nbsp; Aculife Healthcare Pvt Ltd

10.12&nbsp;&nbsp;&nbsp; Hormel Foods Corporation

10.13&nbsp;&nbsp;&nbsp; BASF SE

10.14&nbsp;&nbsp;&nbsp; Meiji Holdings Co Ltd.

10.15&nbsp;&nbsp;&nbsp; Grifols SA 
&nbsp;

US Clinical Nutrition Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters